Where is Qtonics located?

Qtonics is headquartered in Vancouver, United States.

Where does Qtonics rank among its competitors?

Qtonics ranks 573rd amongst 778 active competitors, of which 48 are funded. It stands 11th in terms of total funding among its competitors. The most recent competitor to raise funding was BioLamina, which secured $23.6M in Apr, 2026.

Who are the top competitors of Qtonics?

Qtonics' top competitors include Abcam, Enzo and Meridian Bioscience. Among them, BioLamina secured the most recent funding round in April, 2026.

Qtonics - 2026 Company Profile, Team, Funding & Competitors

Qtonics is a funded company based in Vancouver (United States), founded in 2018. It operates as a Provider of chemicals and reagents for research and institutes. The company has 778 active competitors, including 48 funded and 94 that have exited. Its top competitors include companies like Abcam, Enzo and Meridian Bioscience.

Company Details

Provider of chemicals and reagents for research and institutes. The company offers chemicals, antibodies, ELISA kits, recombinant proteins, small molecules, and lab supplies.

Website: qtonics.com
Email ID: *****@qtonics.com
Phone Number: +1 **********

Key Metrics

Founded Year

2018

Location

Vancouver, United States

Stage

Funding Raised

Investors

OTRADI

Ranked

573^rd among 778 active competitors

Similar Companies

Abcam & 916 more

View Qtonics' full profile

Qtonics is a funded company. Qtonics has 1 institutional investor.

View details of Qtonics's funding rounds and investors

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Qtonics include Abcam, Enzo and Meridian Bioscience. Here is the list of Top 10 competitors of Qtonics, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Abcam 1998, Cambridge (United Kingdom), Acquired	Developer of biological reagents for life science research	$78.8M	Juno Investment Partners, Martlet Capital ... & 2 others	76/100
2nd	Enzo 1976, Farmingdale (United States), Acquired	Life science products and services for research, drug discovery, and manufacturing	$7M	-	65/100
3rd	Meridian Bioscience 1976, Ohio (United States), Acquired	Molecular diagnostic device and kits	-	JobsOhio, NIH	65/100
4th	Firefly BioWorks 2009, Cambridge (United States), Acquired	Develops platform to allow multiplexed assays on standard laboratory instrumentation	$3.77M	Breton Capital Ventures, PBM Capital & 3 others	59/100
5th	Huwel Life 2015, Hyderabad (India), Series A	Molecular diagnostic solutions and products for the healthcare industry	$5.74M	Bartronics, BIRAC & 3 others	59/100
6th	Stem Cell Technologies 1993, Vancouver (Canada), Series A	Developer of cell culture media and ancillary reagents for life science research	$11.9M	National Research Council Canada, BDC & 1 others	58/100
7th	BioLamina 2008, Sundbyberg (Sweden), Series B	Cell culture reagents for stem cell research	$18.2M	Lauxera Capital Partners, Bure Equity & 5 others	56/100
8th	Teknova 1996, Hollister (United States), Public	Provider of molecular biology research reagents and kits	-	Cambrian Growth Partners, Telegraph Hill Partners ... & 1 others	55/100
9th	Luminex 1995, Austin (United States), Acquired	Developer of instruments, reagents and kits for clinical diagnostics and life science research	-	Public Health Emergency, National Science Foundation ... & 1 others	55/100
10th	PL BioScience 2015, Aachen (Germany), Series A	Manufacturer of human platelet lysate products for cell culture applications	$13M	TechVision Fonds, Brightlands Venture Partners ... & 18 others	55/100
573rd	Qtonics 2018, Vancouver (United States), Funding Raised	Provider of chemicals and reagents for research and institutes	-	OTRADI	22/100